Medicaid coverage for nonsteroidal topical atopic dermatitis treatment is often restrictive and variable across the United States
E. Kim(Harvard University), Tina Ho(Boston Children's Hospital), John S. Barbieri(Brigham and Women's Hospital), Sherry Ershadi
Cited by 1
Related Papers
A Kinetic Model for Step Coverage by Atomic Layer Deposition in Narrow Holes or Trenches
|Chemical Vapor Deposition|2003|390
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Acne Vulgaris
|JAMA Dermatology|2022|46
Low-count whole-body PET/MRI restoration: an evaluation of dose reduction spectrum and five state-of-the-art artificial intelligence models
|European Journal of Nuclear Medicine and Molecular Imaging|2023|26
OA 05.05 Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Updated Efficacy and Safety Results From ALTA, a Randomized Phase 2 Trial
|Journal of Thoracic Oncology|2017|20